Hydrogen peroxide modulates immunoglobulin expression by targeting the 3′Igh regulatory region through an NFκB-dependent mechanism

References

• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39:44–84.
   PubMed Web of Science ®Google Scholar
• Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002;3:1129–1134.
   PubMed Web of Science ®Google Scholar
• Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992;175:1181–1194.
   PubMed Web of Science ®Google Scholar
• Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. Embo J 1991;10:2247–2258.
   PubMed Web of Science ®Google Scholar
• Israel N, Gougerot-Pocidalo MA, Aillet F, Virelizier JL. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol 1992;149: 3386–3393.
   PubMed Web of Science ®Google Scholar
• Rio MJ, Velez-Pardo C. Paraquat induces apoptosis in human lymphocytes: protective and rescue effects of glucose, cannabinoids and insulin-like growth factor-1. Growth Factors 2008;26:49–60.
   PubMed Web of Science ®Google Scholar
• Sanchez-Duffhues G, Calzado MA, de Vinuesa AG, Appendino G, Fiebich BL, Loock U, . Denbinobin inhibits nuclear factor-kappaB and induces apoptosis via reactive oxygen species generation in human leukemic cells. Biochem Pharmacol 2009;77:1401–1409.
   PubMed Web of Science ®Google Scholar
• Oliveira-Marques V, Marinho HS, Cyrne L, Antunes F. Role of hydrogen peroxide in NF-kappaB activation: from inducer to modulator. Antioxid Redox Signal 2009;11:2223–2243.
   PubMed Web of Science ®Google Scholar
• Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, Aggarwal BB. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem 2003;278:24233–24241.
   PubMed Web of Science ®Google Scholar
• Liu J, Yoshida Y, Yamashita U. Suppressive effect of reactive oxygen species on CD40-induced B cell activation. FEBS Lett 2007;581:5043–5049.
   PubMed Web of Science ®Google Scholar
• Doi TS, Takahashi T, Taguchi O, Azuma T, Obata Y. NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med 1997;185:953–961.
   PubMed Web of Science ®Google Scholar
• Hsing Y, Bishop GA. Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J Immunol 1999;162:2804–2811.
   PubMed Web of Science ®Google Scholar
• Lieberson R, Ong J, Shi X, Eckhardt LA. Immunoglobulin gene transcription ceases upon deletion of a distant enhancer. Embo J 1995;14:6229–6238.
   PubMed Web of Science ®Google Scholar
• Vincent-Fabert C, Fiancette R, Pinaud E, Truffinet V, Cogne N, Cogne M, Denizot Y. Genomic deletion of the whole IgH 3′ regulatory region (hs3a, hs1,2, hs3b, hs4) dramatically affects class switch recombination and Ig secretion to all isotypes. Blood 2010;116:1895–1898.
   PubMed Web of Science ®Google Scholar
• Michaelson JS, Singh M, Snapper CM, Sha WC, Baltimore D, Birshtein BK. Regulation of 3′ IgH enhancers by a common set of factors, including kappa B-binding proteins. J Immunol 1996;156:2828–2839.
   PubMed Web of Science ®Google Scholar
• Khamlichi AA, Pinaud E, Decourt C, Chauveau C, Cogne M. The 3′ IgH regulatory region: a complex structure in a search for a function. Adv Immunol 2000;75:317–345.
   PubMed Web of Science ®Google Scholar
• Wang J, Boxer LM. Regulatory elements in the immunoglobulin heavy chain gene 3′-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. J Biol Chem 2005;280:12766–12773.
   PubMed Web of Science ®Google Scholar
• Tolusso B, Frezza D, Mattioli C, Fedele AL, Bosello S, Faustini F, . Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann Rheum Dis 2009;68:416–419.
   PubMedGoogle Scholar
• Cerimele F, Battle T, Lynch R, Frank DA, Murad E, Cohen C, . Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt’s lymphoma. Proc Natl Acad Sci USA 2005;102: 175–179.
   PubMed Web of Science ®Google Scholar
• Pedersen-Lane JH, Zurier RB, Lawrence DA. Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients. J Leukoc Biol 2007;81:934–941.
   PubMed Web of Science ®Google Scholar
• Arnold LW, LoCascio NJ, Lutz PM, Pennell CA, Klapper D, Haughton G. Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J Immunol 1983;131:2064–2068.
   PubMed Web of Science ®Google Scholar
• Henseler RA, Romer EJ, Sulentic CE. Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3′immunoglobulin heavy chain regulatory region. Toxicology 2009;261:9–18.
   PubMed Web of Science ®Google Scholar
• Ong J, Stevens S, Roeder RG, Eckhardt LA. 3′ IgH enhancer elements shift synergistic interactions during B cell development. J Immunol 1998;160:4896–4903.
   PubMed Web of Science ®Google Scholar
• Arenzana-Seisdedos F, Fernandez B, Dominguez I, Jacque JM, Thomas D, Diaz-Meco MT, . Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes. J Virol 1993;67:6596–604.
   PubMed Web of Science ®Google Scholar
• Sulentic CE, Kaminski NE. The long winding road toward understanding the molecular mechanisms for B cell suppression by 2,3,7,8-tetrachlorodibenz-p-dioxin. Toxicol Sci;120:S171–S191.
   Google Scholar
• Yao Y, Hoffer A, Chang CY, Puga A. Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme. Environ Health Perspect 1995;103:366–371.
   PubMed Web of Science ®Google Scholar
• Reichard JF, Dalton TP, Shertzer HG, Puga A. Induction of oxidative stress responses by dioxin and other ligands of the aryl hydrocarbon receptor. Dose Response 2005;3:306–331.
   Google Scholar
• Sulentic CE, Holsapple MP, Kaminski NE. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J Pharmacol Exp Ther 2000;295:705–716.
   PubMed Web of Science ®Google Scholar
• Sulentic CE, Zhang W, Na YJ, Kaminski NE. 2,3,7,8-tetrachlorodibenzo-p-dioxin, an exogenous modulator of the 3′alpha immunoglobulin heavy chain enhancer in the CH12.LX mouse cell line. J Pharmacol Exp Ther 2004;309:71–78.
   PubMed Web of Science ®Google Scholar
• Rice NR, Ernst MK. In vivo control of NF-kappa B activation by I kappa B alpha. Embo J 1993;12:4685–4695.
   PubMedGoogle Scholar
• Reuther JY, Baldwin AS, Jr. Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. J Biol Chem 1999;274:20664–20670.
   PubMed Web of Science ®Google Scholar
• Sulentic CE, Holsapple MP, Kaminski NE. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol Pharmacol 1998;53:623–629.
   PubMed Web of Science ®Google Scholar
• Carta S, Castellani P, Delfino L, Tassi S, Vene R, Rubartelli A. DAMPs and inflammatory processes: the role of redox in the different outcomes. J Leukoc Biol 2009;86:549–555.
   PubMed Web of Science ®Google Scholar
• Los M, Droge W, Stricker K, Baeuerle PA, Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol 1995;25:159–165.
   PubMed Web of Science ®Google Scholar
• Snapper CM, Yamada H, Smoot D, Sneed R, Lees A, Mond JJ. Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol 1993;150:2737–2745.
   PubMed Web of Science ®Google Scholar
• Mordmuller B, Krappmann D, Esen M, Wegener E, Scheidereit C. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism. EMBO Rep 2003;4:82–87.
   PubMed Web of Science ®Google Scholar
• Krappmann D, Wegener E, Sunami Y, Esen M, Thiel A, Mordmuller B, Scheidereit C. The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol Cell Biol 2004;24:6488–6500.
   PubMed Web of Science ®Google Scholar
• Laurencikiene J, Deveikaite V, Severinson E. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions. J Immunol 2001;167:3257–3265.
   PubMed Web of Science ®Google Scholar
• Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, . Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell 1996;86:787–798.
   PubMed Web of Science ®Google Scholar
• Ju Z, Volpi SA, Hassan R, Martinez N, Giannini SL, Gold T, Birshtein BK. Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3′ regulatory region. J Biol Chem 2007;282:35169–35178.
   PubMed Web of Science ®Google Scholar